Kidney stone disease
- PMID: 16200192
- PMCID: PMC1236703
- DOI: 10.1172/JCI26662
Kidney stone disease
Abstract
About 5% of American women and 12% of men will develop a kidney stone at some time in their life, and prevalence has been rising in both sexes. Approximately 80% of stones are composed of calcium oxalate (CaOx) and calcium phosphate (CaP); 10% of struvite (magnesium ammonium phosphate produced during infection with bacteria that possess the enzyme urease), 9% of uric acid (UA); and the remaining 1% are composed of cystine or ammonium acid urate or are diagnosed as drug-related stones. Stones ultimately arise because of an unwanted phase change of these substances from liquid to solid state. Here we focus on the mechanisms of pathogenesis involved in CaOx, CaP, UA, and cystine stone formation, including recent developments in our understanding of related changes in human kidney tissue and of underlying genetic causes, in addition to current therapeutics.
Figures




Similar articles
-
An update and practical guide to renal stone management.Nephron Clin Pract. 2010;116(3):c159-71. doi: 10.1159/000317196. Epub 2010 Jul 2. Nephron Clin Pract. 2010. PMID: 20606476 Review.
-
Plasma levels and urinary excretion of amino acids by subjects with renal calculi.Amino Acids. 2010 May;38(5):1277-82. doi: 10.1007/s00726-009-0359-z. Epub 2009 Sep 29. Amino Acids. 2010. PMID: 19787430 Review.
-
[Studies on urolithiasis. The histochemistry of the kidney tissues and stones from patients with urolithiasis].Hinyokika Kiyo. 1986 Jan;32(1):27-42. Hinyokika Kiyo. 1986. PMID: 2938457 Japanese.
-
Composition of renal stones and their frequency in a stone clinic: relationship to parameters of mineral metabolism in serum and urine.Urol Res. 1979 Sep;7(3):161-70. doi: 10.1007/BF00257201. Urol Res. 1979. PMID: 505679
-
Metabolic stone composition in Egyptian children.J Pediatr Urol. 2009 Apr;5(2):132-5. doi: 10.1016/j.jpurol.2008.11.002. Epub 2008 Dec 6. J Pediatr Urol. 2009. PMID: 19059808
Cited by
-
Resveratrol Attenuates Oxalate-Induced Renal Oxidative Injury and Calcium Oxalate Crystal Deposition by Regulating TFEB-Induced Autophagy Pathway.Front Cell Dev Biol. 2021 Feb 25;9:638759. doi: 10.3389/fcell.2021.638759. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33718378 Free PMC article.
-
Impact on urinary oxalate levels with use of ezetimibe.Endocrinol Diabetes Metab. 2021 Jan 4;4(2):e00221. doi: 10.1002/edm2.221. eCollection 2021 Apr. Endocrinol Diabetes Metab. 2021. PMID: 33855221 Free PMC article.
-
Bacteria can promote calcium oxalate crystal growth and aggregation.J Biol Inorg Chem. 2013 Mar;18(3):299-308. doi: 10.1007/s00775-012-0974-0. Epub 2013 Jan 20. J Biol Inorg Chem. 2013. PMID: 23334195
-
Development of a Humanized Murine Model for the Study of Oxalobacter formigenes Intestinal Colonization.J Infect Dis. 2019 Oct 22;220(11):1848-1858. doi: 10.1093/infdis/jiz370. J Infect Dis. 2019. PMID: 31328778 Free PMC article.
-
A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats.Urol Res. 2008 Feb;36(1):17-24. doi: 10.1007/s00240-007-0122-4. Epub 2007 Nov 27. Urol Res. 2008. PMID: 18040675
References
-
- Zarse CA, et al. Helical computed tomography accurately reports urinary stone composition using attenuation values: in vitro verification using high-resolution micro-computed tomography calibrated to fourier transform infrared microspectroscopy. Urology. 2004;63:828–833. - PubMed
-
- Lingeman JE, Kim SC, Kuo RL, McAteer JA, Evan AP. Shockwave lithotripsy: anecdotes and insights. J. Endourol. 2003;17:687–693. - PubMed
-
- Bagley DH. Expanding role of ureteroscopy and laser lithotripsy for treatment of proximal ureteral and intrarenal calculi. Curr. Opin. Urol. 2002;12:277–280. - PubMed
-
- Clayman RV. Percutaneous nephrolithotomy: an update [comment] J. Urol. 2005;173:1199. - PubMed
-
- Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005;67:685–690. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous